NCT07480122Not yet recruiting
Motor Imaging, Neglect, and Upper Extremity Function in Stroke
Investigation of the Relationship Between Motor Imagery Skill and Neglect Level, Upper Extremity Motor Function, Activities of Daily Living, and Quality of Life in Individuals After Stroke
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
This study aims to investigate the relationship between motor imagery skills and neglect level, upper extremity motor function, activities of daily living, quality of life, lateralization performance, and mental timer performance in individuals with stroke. Individuals with stroke who meet the inclusion criteria and voluntarily agree to participate will be evaluated. Demographic and clinical information of the participants will be recorded on an assessment form prepared by the researcher. Upper extremity motor functions will be assessed using the Fugl-Meyer Upper Extremity Motor Assessment Scale and the Wolf Motor Function Test; activities of daily living will be assessed using the Modified Barthel Index; and quality of life will be assessed using the Stroke-Specific Quality of Life Scale. Motor imagery skills will be measured using the Kinesthetic and Visual Imagery Questionnaire and a mental timer task; upper extremity lateralization performance will be assessed using the Recognise™ application. Neglect level will be assessed using the Catherine Bergego Scale, the Line Splitting Test, and the Star Erase Test. The data obtained will be statistically analyzed to examine the relationships between motor imagery skills and other clinical variables.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 13 Mar 2026
- Start date
- May 2026
- Primary completion date
- Jun 2026
- Lead sponsor
- Inonu University
- Diseases
- Stroke
- NCT number
- NCT07480122
What you commit to
- Study type: Observational
- Planned participants: 50
- From May 2026 to the primary completion date, Jun 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Individuals with active malignancy and receiving related chemo/radiotherapy,
Other illness
- Individuals with major neurological, orthopedic, or rheumatological disorders affecting upper extremity function other than stroke (Polyneuropathy, Parkinson's Disease, Multiple Sclerosis, Rheumatoid Arthritis, etc.),
- Individuals with uncontrolled arrhythmia, uncontrolled hypertension, or unstable cardiac conditions,
- Individuals unable to cooperate due to aphasia or cognitive impairment,
Other
- Individuals with upper extremity amputation,
- Individuals with visual and hearing problems,
- Individuals with communication problems that would hinder the evaluation and/or implementation of the treatment program,
- Individuals who are unable to undergo mental assessment, complete the scales, or are illiterate will be excluded from the study.
Who the study is looking for
- Individuals who have experienced hemiplegia after an ischemic stroke,
- who actively use their right extremity according to the Edinburgh Hand Preference Questionnaire,
- who have right hemisphere involvement,
- who are 18 years of age or older,
- who have been diagnosed with a stroke at least 1 and at most 6 months ago,
- who have middle cerebral artery involvement,
- who have a Standardized Mini Mental Test score of 24 or higher,
- who are Stage 2b or higher according to Eggers staging,
- who can actively control their hand, wrist, and fingers and perform the release reflex,
- who wish to participate in the study voluntarily, and
- who have given their informed consent will be included in the research.
Age in the registry: 30 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.